IDEV Technologies, Inc. developed the Supera™ stent for the treatment of peripheral artery disease. The use of interwoven, individual, flexible nitinol wires enables a unique combination of high compression resistance, low chronic outward force, high flexibility and fracture resistance.

Acquired by Abbott in August 2013.